
TRT and Prostate Health: Growth Factors and Hyperplasia in American Men
Reading Time: 2 minutes Introduction Testosterone replacement therapy (TRT) has become a common intervention for men experiencing hypogonadism, a condition characterized by low levels of testosterone. While TRT can significantly improve quality of life, concerns about its impact on prostate health, particularly the risk of benign prostatic hyperplasia (BPH), remain a focal point in urological research. This article delves into the molecular mechanisms, specifically the expression of growth factors in prostatic tissue following the initiation of TRT, and their role in mediating hyperplasia among American men. The Role of Testosterone in Prostatic Health Testosterone, the primary male sex hormone, plays a crucial role in...